Health knowledge made personal
Join this community!
› Share page:
Search posts:

List of US Government Support for Vaccine-Autism Studies

Posted Mar 01 2011 12:00am

Open-door-field Despite the hutesium et clamor from the media and industry, the autism vaccine scientific debate is not  closed.


  Office of Immunization Safety (OSI)
US Centers for Disease Control and Prevention (CDC)

● Will study autism as a possible clinical outcome of immunization.

● Will study mitochondrial dysfunction and the risk for “post-vaccine neurological deterioration.”

● Will convene an expert panel on the feasibility of studying health outcomes such as autism among vaccinated and unvaccinated children.

National Vaccine Advisory Committee (NVAC)
US Department of Health and Human Services (HHS)

● Calls for the study of adverse events following immunization (e.g., fever and seizures) to see if they increase autism risk.

● Calls for an external expert committee to consider “strengths and weaknesses, ethical issues and feasibility of examining outcomes in unvaccinated, vaccine delayed and vaccinated children.”

● Calls for the inclusion of autism as an outcome in the vaccine study.

● Calls for more research on “the possible occurrence of ASD in a small number of children subsequent to MMR vaccination” especially given “recent research around the incidence of mitochondrial dysfunction in children with an ASD phenotype.”

● Calls for studying adverse vaccine reactions in subsets of the ASD spectrum, especially in light of “recent developments around mitochondrial dysfunction.”

● Reports that some subsets (ie, those with mitochondrial dysfunction) “may be at elevated risk of reduced neurological functioning, possibly including developing ASD, subsequent to vaccination.”

● Reports that, “in the context of vaccination research, the ASD clinical subset of particular interest is regressive autism.”

● Concludes that “public concern regarding vaccines and autism, coupled with the prevalence and severity of ASD, warrant additional study in well defined subpopulations.”

Interagency Autism Coordinating Committee (IACC)
Includes CDC, HHS, NIH and Health Resources and Services Administration (HRSA)

● Will fund studies of environmental risk factors for ASD, such as toxic exposures and "adverse events following immunization (such as fever and seizures), and mitochondrial impairment."

● Will fund studies to determine if some subpopulations are “more susceptible to environmental exposures (e.g., immune challenges related to infections, vaccinations, or underlying autoimmune problems)."

● Will continue to coordinate with the National Vaccine Advisory Committee (NVAC), ”To address public concerns regarding a possible vaccine/ASD link

● Will monitor scientific literature “regarding possible associations of vaccines and other environmental factors with ASD to identify emerging opportunities for research.”

● Concludes that existing population-based vaccine-autism studies were “limited in their ability to detect small susceptible subpopulations.”
Vaccine Injury Compensation Program (VICP)
Health Resources and Services Administration (HRSA), HHS

● An Institute of Medicine (IOM) committee will consider adverse events from the  DtaP vaccine, including autism and autism spectrum disorders, on behalf of VICP.

● The IOM committee will also consider adverse events from the MMR vaccine, including autism and autism spectrum disorders, on behalf of VICP.

● The committee will consider vaccine-associated “secondary” autism or autistic features arising from chronic encephalopathy, mitochondrial disorders and/or other underlying disorders.

● VICP has asked the committee to consider “primary autism” in light of “recent theories of neuro-inflammation and hyper-arousal/over-excitation of the immune system via multiple simultaneous antigenic stimulation” (several vaccines at once).

Posted by Age of Autism at March 21, 2011 at 5:43 AM in Current Affairs , Science , Vaccine Safety Permalink

Post a comment
Write a comment:

Related Searches